IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma

Exploration of Potential Genomic Portraits Associated with Intrahepatic Recurrence in Human Hepatocellular Carcinoma

(2010) Nobuyoshi Kittaka et al.   ANNALS OF SURGICAL ONCOLOGY

Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells

(2010) Y Tomimaru et al.   BRITISH JOURNAL OF CANCER

Reactivation of IGFBP7 by DNA demethylation inhibits human colon cancer cell growth in vitro

(2010) Jie Lin et al.   CANCER BIOLOGY & THERAPY

IGFBP7: an oncosuppressor gene in thyroid carcinogenesis

(2010) M G Vizioli et al.   ONCOGENE

Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery

(2010) Takehiro Noda et al.   SURGERY

Molecular prediction of early recurrence after resection of hepatocellular carcinoma

(2009) Shinichi Yoshioka et al.   EUROPEAN JOURNAL OF CANCER

Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells

(2009) Kazuhiro Tamura et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines

(2009) N. Wajapeyee et al.   MOLECULAR CANCER THERAPEUTICS

Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7

(2008) Narendra Wajapeyee et al.   CELL

Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data

(2008) Nobuyoshi Kittaka et al.   EUROPEAN JOURNAL OF CANCER